Toffoli G, Franchin G, Barzan L, Cernigoi C, Carbone A, Sulfaro S, Franceschi S, Boiocchi M
Division of Experimental Oncology 1, Centro di Riferimento Oncologico, Aviano, Italy.
Laryngoscope. 1995 Jun;105(6):649-52. doi: 10.1288/00005537-199506000-00017.
One hundred fifty-two unselected, consecutive patients with T1-2N0 laryngeal squamous cell carcinoma received radical radiation therapy at the Division of Radiotherapy, Centro di Riferimento Oncologico, Aviano, Italy. Thirty-one (20.4%) of the patients showed disease recurrence or persistence (R/P) after radiotherapy. Flow-cytometric DNA ploidy measurements were performed in 72 cases; 20 had tumor R/P and 52 did not. Tumor R/P occurred more frequently (in 17 [85%] of 20 cases) in patients with diploid tumors. The hazard ratio of recurrence in diploid tumors as compared with aneuploid tumors, after inclusion of all the other significant prognostic factors in a Cox proportional hazards model, was 8.9 (P < .01). Therefore DNA ploidy seems to be an important marker of tumor R/P in patients with T1-2N0 laryngeal carcinoma after radiotherapy.
152例未经挑选的连续性T1-2N0期喉鳞状细胞癌患者在意大利阿维亚诺肿瘤参考中心放疗科接受了根治性放射治疗。31例(20.4%)患者在放疗后出现疾病复发或持续存在(R/P)。对72例患者进行了流式细胞术DNA倍体检测;其中20例有肿瘤R/P,52例没有。二倍体肿瘤患者中肿瘤R/P更为常见(20例中有17例[85%])。在Cox比例风险模型纳入所有其他显著预后因素后,二倍体肿瘤与非整倍体肿瘤相比的复发风险比为8.9(P < 0.01)。因此,DNA倍体似乎是T1-2N0期喉癌患者放疗后肿瘤R/P的一个重要标志物。